QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AQST

QT71Aquestive Therapeutics, Inc.
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·USA
Latest market price
4.71
+0.28+6.32%
OverviewShort InterestFilings
AQSTQT71Aquestive Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
4.71+6.32%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01LNTH+0.65%$103.86
Snapshot
Index-P/E-EPS (ttm)
-0.61
Insider Own8.73%
Shs Outstand125.45M
Perf Week11.88%
Market Cap439.93MForward P/E-EPS next Y-0.38Insider Trans-0.34%Shs Float-Perf Month15.16%
Enterprise Value462.77MPEG0.66EPS next Q-0.10Inst Own-Short Float-Perf Quarter16.01%
Income-55826914.00P/S8.75EPS this Y32.79%Inst Trans-Short Ratio-Perf Half Y-19.07%
Sales50.27MP/B-EPS next Y7.32%ROA-48.83%Short Interest-Perf YTD-27.09%
Book/sh-0.27P/C-EPS next 5Y-ROE190.87%52W High7.55 -37.62%Perf Year40.60%
Cash/sh0.88P/FCF-EPS past 3/5Y-ROIC-44.82%52W Low2.93 60.75%Perf 3Y-
Dividend Est.-EV/EBITDA-8.96Sales past 3/5Y-2.13% -0.44%Gross Margin63.45%Volatility2.56% 2.51%Perf 5Y-
Dividend TTM-EV/Sales9.21EPS Y/Y TTM-19.61%Oper. Margin-111.18%ATR (14)0.19Perf 10Y-
Dividend Ex-Date-Quick Ratio3.85Sales Y/Y TTM-13.79%Profit Margin-137.08%RSI (14)69.67Recom2.00
Dividend Gr. 3/5Y-Current Ratio4.10EPS Q/Q70.83%SMA2014.33%Beta1.39Target Price9.00
Payout0.00%Debt/Eq-3.92Sales Q/Q55.56%SMA5013.04%Rel Volume1.96Prev Close4.43
Employees142LT Debt/Eq-3.50EarningsAug 10SMA200-3.72%Avg Volume1.54MPrice4.71
IPO DateJul 25, 2018Option/ShortYes / YesEPS/Sales Surpr.50.00% 27.27%Net Debt/EBITDA-0.44Volume3,016,901Change6.32%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-03-26ReiteratedLake StreetBuy$8.00 → $6.00
Feb-02-26ReiteratedNew Street$12
Oct-09-25ReiteratedJMP SecuritiesMarket Outperform$12
Mar-07-25ReiteratedRaymond James$8.00 → $7.00
Nov-06-24ReiteratedLoop Capital Markets$7.00 → $10
Jun-25-24ReiteratedLoop Capital Markets$7.00
Apr-11-24ReiteratedPiper Sandler$10
Mar-18-24ReiteratedH.C. Wainwright$9.00
Mar-15-24ReiteratedOppenheimer$12
Mar-09-23UpgradeWedbushNeutral → Outperform
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue504558
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A191718
Gross Profit312740
Selling, General and Administrative Excl. Other728050
Research and Development161720
Other Operating Expense000
Operating Income-55-70-31
Interest Expense161717
Unusual Expense
———
Non-Operating Income (Expense)-3-3-3
Net Income Before Taxes-69-84-44
Income Taxes
000
Consolidated Net Income-69-84-44
Net Income From Continuing Operations-69-84-44
Net Income-69-84-44
EPS (Recurring)-0.61-0.76-0.51
EPS (Basic, Before Extraordinaries)-0.61-0.76-0.51
EPS (Diluted)-0.61-0.76-0.51
EBITDA-51-66-27
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio11.5917.51—
Gross Margin62.0060.0068.97
Operating Margin-110.00-155.56-53.45
Net Margin-138.00-186.67-75.86
Shares Outstanding12312287
Market Capitalization579788—
Operating Lease Expense
———
Insider Trading Volume
$5.09$4.68$4.26$3.84$3.43● Close Price0.00M0.41M0.83M1.24M1.65MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Barber DanielPresident and CEOJun 15 '26Sale4.1625,000104,010635,574Jun 16 12:00 AM
Barber DanielPresident and CEOMay 15 '26Sale4.298,25735,413660,574May 18 12:00 AM
BRAENDER LORI JChief Legal OfficerMar 10 '26Sale4.1740,102167,346442,879Mar 11 12:00 AM
Boyd Peter E.Chief People OfficerMar 10 '26Sale4.1729,814124,414338,509Mar 11 12:00 AM
Jung CassieChief Operating OfficerMar 10 '26Sale4.1745,791191,086274,980Mar 11 12:00 AM
Korczynski SherryChief Commercial OfficerMar 10 '26Sale4.1715,74165,687241,117Mar 11 12:00 AM
Barber DanielPresident and CEOMar 10 '26Sale4.17180,677753,9651,004,753Mar 11 12:00 AM
TOTH A ERNEST JRChief Financial OfficerMar 10 '26Sale4.1758,254243,094376,112Mar 11 12:00 AM
Cioffi MelinaSVP, Regulatory AffairsMar 10 '26Sale4.1725,311105,623274,867Mar 11 12:00 AM
Jung CassieChief Operating OfficerOct 15 '25Option Exercise3.1050,000155,136308,346Oct 17 12:00 AM
Jung CassieChief Operating OfficerOct 15 '25Sale7.0167,575473,701240,771Oct 17 12:00 AM
Kraus Carl NChief Medical OfficerOct 15 '25Sale7.0020,272141,904282,475Oct 17 12:00 AM
Boyd Peter E.See RemarksOct 15 '25Sale7.0010,00070,000268,323Oct 17 12:00 AM
Barber DanielPresident and CEOSep 26 '25Sale6.0391,343551,191923,430Sep 29 12:00 AM
Boyd Peter E.See RemarksSep 26 '25Sale6.3010,00063,000278,323Sep 29 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR